Literature DB >> 29747127

Wideband LGE MRI permits unobstructed viewing of myocardial scarring in a patient with an MR-conditional subcutaneous implantable cardioverter-defibrillator.

Amir Ali Rahsepar1, Jeremy D Collins1, Bradley P Knight2, KyungPyo Hong1, James C Carr1, Daniel Kim3.   

Abstract

A subcutaneous implantable cardioverter-defibrillator (S-ICD) is an alternative device for prevention of sudden cardiac death, without any leads within the heart. Patients implanted with any type of ICD may need catheter ablation of ventricular tachycardia (VT) to reduce the overall arrhythmia burden (e.g., recurrent monomorphic VT) and lower the incidence of painful shocks induced by the device. Late gadolinium enhancement (LGE) MRI is a useful pre-test for guiding VT ablation, because it can be used to map myocardial scar and produce better outcomes. Growing evidence suggests that MRI can be performed with manageable risks on patients with a cardiac implantable electronic device (CIED). Nonetheless, the diagnostic yield of cardiac MRI is still low because of severe image artifacts, regardless of MR-conditional or non-MR conditional labeling. Image artifacts in the heart induced by an S-ICD is expected to be larger than the artifacts induced by a transvenous ICD, because the former is twice as large in size and implanted closer to the heart. This is the first reported case of successful wideband LGE MRI in a patient implanted with an MR-conditional S-ICD. A 37-year-old man with ischemic cardiomyopathy was referred for a cardiac MRI at 1.5 T ten months after S-ICD implantation, in order to rule out constrictive pericarditis. Clinical standard LGE MRI produced severe image artifacts, rendering it useless. In contrast, wideband LGE MRI provided unobstructed viewing of myocardial scarring. This case illustrates the usefulness of wideband LGE MRI for assessment of myocardial scarring in a patient with an MR-conditional S-ICD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Image artifacts; LGE MRI; S-ICD; Wideband

Mesh:

Substances:

Year:  2018        PMID: 29747127      PMCID: PMC6015543          DOI: 10.1016/j.clinimag.2018.05.005

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  24 in total

1.  QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy.

Authors:  Jagdesh Kandala; Gaurav A Upadhyay; Robert K Altman; Kimberly A Parks; Mary Orencole; Theofanie Mela; E Kevin Heist; Jagmeet P Singh
Journal:  Eur Heart J       Date:  2013-04-09       Impact factor: 29.983

2.  HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.

Authors:  Fred M Kusumoto; Hugh Calkins; John Boehmer; Alfred E Buxton; Mina K Chung; Michael R Gold; Stefan H Hohnloser; Julia Indik; Richard Lee; Mandeep R Mehra; Venu Menon; Richard L Page; Win-Kuang Shen; David J Slotwiner; Lynne Warner Stevenson; Paul D Varosy; Lisa Welikovitch
Journal:  J Am Coll Cardiol       Date:  2014-05-09       Impact factor: 24.094

3.  A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.

Authors:  Saman Nazarian; Rozann Hansford; Ariel Roguin; Dorith Goldsher; Menekhem M Zviman; Albert C Lardo; Brian S Caffo; Kevin D Frick; Michael A Kraut; Ihab R Kamel; Hugh Calkins; Ronald D Berger; David A Bluemke; Henry R Halperin
Journal:  Ann Intern Med       Date:  2011-10-04       Impact factor: 25.391

4.  Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.

Authors:  Saman Nazarian; Ariel Roguin; Menekhem M Zviman; Albert C Lardo; Timm L Dickfeld; Hugh Calkins; Robert G Weiss; Ronald D Berger; David A Bluemke; Henry R Halperin
Journal:  Circulation       Date:  2006-09-11       Impact factor: 29.690

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations.

Authors:  Torsten Sommer; Claas P Naehle; Alexander Yang; Volkert Zeijlemaker; Matthias Hackenbroch; Alexandra Schmiedel; Carsten Meyer; Katharina Strach; Dirk Skowasch; Christian Vahlhaus; Harold Litt; Hans Schild
Journal:  Circulation       Date:  2006-09-11       Impact factor: 29.690

7.  Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices.

Authors:  Shams Rashid; Stanislas Rapacchi; Marmar Vaseghi; Roderick Tung; Kalyanam Shivkumar; J Paul Finn; Peng Hu
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

8.  The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.

Authors:  Sanjay Dandamudi; Jeremy D Collins; James C Carr; Pat Mongkolwat; Amir A Rahsepar; Todd T Tomson; Nishant Verma; Rishi Arora; Alex B Chicos; Susan S Kim; Albert C Lin; Rod S Passman; Bradley P Knight
Journal:  Acad Radiol       Date:  2016-10-04       Impact factor: 3.173

Review 9.  Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update.

Authors:  Christopher M Kramer; Jörg Barkhausen; Scott D Flamm; Raymond J Kim; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-10-08       Impact factor: 5.364

10.  Generator and lead-related complications of implantable cardioverter defibrillators.

Authors:  Ahmad Yaminisharif; Nader Soofizadeh; Akbar Shafiee; Ali Kazemisaeid; Arash Jalali; Ali Vasheghani-Farahani
Journal:  Int Cardiovasc Res J       Date:  2014-04-01
View more
  3 in total

1.  Impact of Wideband Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging on Device-Related Artifacts in Different Implantable Cardioverter-Defibrillator Types.

Authors:  Amita Singh; Wensu Chen; Hena N Patel; Nazia Alvi; Keigo Kawaji; Stephanie A Besser; Roderick Tung; Jiangang Zou; Roberto M Lang; Victor Mor-Avi; Amit R Patel
Journal:  J Magn Reson Imaging       Date:  2021-03-19       Impact factor: 4.813

2.  Evaluation of image quality of wideband single-shot late gadolinium-enhancement MRI in patients with a cardiac implantable electronic device.

Authors:  Sarah M Schwartz; Ashitha Pathrose; Ali M Serhal; Ann B Ragin; Jessica Charron; Bradley P Knight; Rod S Passman; Ryan J Avery; Daniel Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2020-11-13

3.  Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.

Authors:  Viktoria Holtstiege; Claudia Meier; Michael Bietenbeck; Grigorios Chatzantonis; Anca Florian; Julia Köbe; Florian Reinke; Lars Eckardt; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-18       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.